PP309 – Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis
Saša Rink, Slovenia
Source: ERS Lung Science Conference 2021
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: